TY - JOUR
T1 - Synthetic Nanofiber-Reinforced Amniotic Membrane via Interfacial Bonding
AU - Liu, Huanhuan
AU - Zhou, Zhengbing
AU - Lin, Hui
AU - Wu, Juan
AU - Ginn, Brian
AU - Choi, Ji Suk
AU - Jiang, Xuesong
AU - Chung, Liam
AU - Elisseeff, Jennifer H.
AU - Yiu, Samuel
AU - Mao, Hai Quan
N1 - Publisher Copyright:
© 2018 American Chemical Society.
PY - 2018/5/2
Y1 - 2018/5/2
N2 - Severe damage to the ocular surface can result in limbal stem cell (LSC) deficiency, which contributes to loss of corneal clarity, potential vision loss, chronic pain, photophobia, and keratoplasty failure. Human amniotic membrane (AM) is the most effective substrate for LSC transplantation to treat patients with LSC deficiency. However, the widespread use of the AM in the clinic remains a challenge because of the high cost for preserving freshly prepared AM and the weak mechanical strength of lyophilized AM. Here, we developed a novel composite membrane consisting of an electrospun bioabsorbable polymer fiber mesh bonded to a decellularized AM (dAM) sheet through interfacial conjugation. This membrane engineering approach drastically improved the tensile property and toughness of dAM, preserved similar levels of bioactivities as the dAM itself in supporting LSC attachment, growth, and maintenance, and retained significant anti-inflammatory capacity. These results demonstrate that the lyophilized nanofiber-dAM composite membrane offers superior mechanical properties for easy handling and suturing to the dAM, while presenting biochemical cues and basement membrane structure to facilitate LSC transplantation. This composite membrane exhibits major advantages for clinical applications in treating soft tissue damage and LSC deficiency.
AB - Severe damage to the ocular surface can result in limbal stem cell (LSC) deficiency, which contributes to loss of corneal clarity, potential vision loss, chronic pain, photophobia, and keratoplasty failure. Human amniotic membrane (AM) is the most effective substrate for LSC transplantation to treat patients with LSC deficiency. However, the widespread use of the AM in the clinic remains a challenge because of the high cost for preserving freshly prepared AM and the weak mechanical strength of lyophilized AM. Here, we developed a novel composite membrane consisting of an electrospun bioabsorbable polymer fiber mesh bonded to a decellularized AM (dAM) sheet through interfacial conjugation. This membrane engineering approach drastically improved the tensile property and toughness of dAM, preserved similar levels of bioactivities as the dAM itself in supporting LSC attachment, growth, and maintenance, and retained significant anti-inflammatory capacity. These results demonstrate that the lyophilized nanofiber-dAM composite membrane offers superior mechanical properties for easy handling and suturing to the dAM, while presenting biochemical cues and basement membrane structure to facilitate LSC transplantation. This composite membrane exhibits major advantages for clinical applications in treating soft tissue damage and LSC deficiency.
KW - amniotic membrane
KW - composite membrane
KW - electrospinning
KW - limbal stem cell transplantation
KW - macrophage phenotype
KW - nanofibers
UR - http://www.scopus.com/inward/record.url?scp=85046250189&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046250189&partnerID=8YFLogxK
U2 - 10.1021/acsami.8b03087
DO - 10.1021/acsami.8b03087
M3 - Article
C2 - 29613762
AN - SCOPUS:85046250189
SN - 1944-8244
VL - 10
SP - 14559
EP - 14569
JO - ACS Applied Materials and Interfaces
JF - ACS Applied Materials and Interfaces
IS - 17
ER -